ReviewSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026
Cancer-related fatigue in cancer survivors: an updated clinical practice review for healthcare providers.
Review in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The long road after breast cancer: survivorship issues and long-term treatment effects in young women.Frontiers in oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeCancer-related fatigue (CRF) is a persistent and distressing sense of physical, emotional, or cognitive exhaustion that results from cancer or its treatment, affecting approximately 70-100% of individuals diagnosed with cancer. Despite its prevalence and impact, CRF is often underrecognized and insufficiently managed. This review aims to provide healthcare providers with clear, evidence-based guidance to improve the recognition, assessment, and management of CRF across the continuum of cancer care.
methodsA narrative literature review was conducted by searching databases for peer-reviewed studies, clinical guidelines, and expert frameworks. Emphasis was placed on high-quality evidence supporting the recognition, assessment, and management of CRF in people with cancer.
resultsCRF may emerge before treatment, intensify during anti-cancer treatment, and persist long after treatment completion. It is multifactorial in origin and varies in severity and duration. Validated self-report tools such as the Numeric Rating Scale and EORTC QLQ-C30 are essential for accurate screening and assessment. Management should begin with addressing reversible contributors and proceed with individualized, multimodal interventions. Non-pharmacological approaches including structured physical activity, cognitive behavioral therapy, and mindfulness-based techniques have the strongest supporting evidence. Complementary strategies such as massage therapy, nutritional support, and bright light therapy also show potential benefit. Pharmacologic treatments remain limited in efficacy and should be considered only when non-pharmacologic options are insufficient.
conclusionsCRF is a clinically significant and potentially modifiable symptom that warrants routine assessment and personalized management. Integrating evidence-based screening tools and interventions into standard oncology care can improve patient outcomes and overall quality of life.
Indexed as
Identifiers
41706215What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.